EPIPAGE 2 - 10-year Follow-up (RECONAI PROJECT)
EPIPAGE2
EPIPAGE2 Cohort Study Follow up at Ten and a Half Years
1 other identifier
observational
2,383
1 country
1
Brief Summary
Epipage 2 (Epidemiological study on small gestational ages) is a prospective population-based national cohort implemented to better understand the short, mid and long term future of premature children. This study was launched on 28 March 2011 by the researchers of the EPOPé team (Perinatal, Obstetric and Pediatric Epidemiology Research) of the Epidemiology and Biostatistics Research Centre (INSERM U1153), in collaboration with the Inserm 1027 Unit (Epidemiology and Analysis in Public Health: risks, chronic diseases and handicaps) and medical teams of public health and research in 25 French regions. The study focuses on children born before 35 weeks of amenorrhea. 3 follow-up steps for children included in the cohort have already been completed at 1, 2 and 5 and a half years of age. Currently, nearly 4,000 children are still eligible for follow-up. Since the children are 9 years old, the follow-up steps are shared with those set up in another birth cohort, the Elfe cohort (Étude Longitudinale Française depuis l'Enfance, (www.elfe-france.fr) ), as part of the RE-CO-NAI project. The RE-CO-NAI project is a research platform on cohorts of children followed since birth in order to be able to study in a global and multidisciplinary way the major issues of the health, development and socialization of children. This RE-CO-NAI project was funded by the EQUIPEX 2011 call for projects as part of future investments. This protocol, which is part of the RECONAI project, concerns the fully shared follow-up phase, proposed in the 10th year for the children of the two cohorts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2022
CompletedFirst Posted
Study publicly available on registry
February 17, 2022
CompletedStudy Start
First participant enrolled
February 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2022
CompletedMay 16, 2025
March 1, 2025
10 months
February 2, 2022
May 13, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Relationships between prematurity, early growth and cardiometabolic disorders
Different cardiometabolic parameters will be studied (90th percentile waist for age and sex, 90th percentile systolic or diastolic pressure for age and sex)
10 years and a half
Relationship between parenting educational skills and children's quality of life
VSPA scale (Adolescent Experience and Perceived Health)
10 years and a half
Factors influencing children's puberty development
Tanner stage
10 years and a half
Factors influencing the child's fitness and motor skills
Children's Endurance and Motor Ability Test Results upper or equal to 75th percentile of distribution for sex
10 years and a half
Eligibility Criteria
Children born before 35 weeks of amenorrhea still eligible for follow-up at 10 years of age
You may qualify if:
- Children initially included in the Epipage 2 study,
- Not lost to follow up (i.e. having participated in at least one of the Epipage 2 surveys since the age of 1 year),
- Neither parent has expressed a definitive refusal to participate in the follow-up study.
You may not qualify if:
- Refusal of the investigation by one of the two parents or holders of parental authority,
- Residence abroad
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
INSERM (National Institute of Health and Medical Research) - Université Paris Cité, INRAE, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé Team) Center for Epidemiology and Statistics
Paris, 74014, France
Biospecimen
Blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2022
First Posted
February 17, 2022
Study Start
February 17, 2022
Primary Completion
December 21, 2022
Study Completion
December 21, 2022
Last Updated
May 16, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share